RIV Capital Inc (RIV.CX)
0.13
0.00 (0.00%)
CAD |
CNSX |
May 17, 16:00
RIV Capital Profit Margin (Quarterly): -435.2% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -435.2% |
| June 30, 2023 | -511.9% |
| March 31, 2023 | -1.36K% |
| December 31, 2022 | -524.7% |
| September 30, 2022 | -7.68K% |
| June 30, 2022 | -259.1% |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -177.3% |
| December 31, 2020 |
| Date | Value |
|---|---|
| September 30, 2020 | -8.89K% |
| June 30, 2020 | -137.0% |
| March 31, 2020 | -1.53K% |
| December 31, 2019 | -55.17% |
| September 30, 2019 | -360.6% |
| June 30, 2019 | -149.9% |
| March 31, 2019 | -70.40% |
| December 31, 2018 | |
| September 30, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | -1.72K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-8.89K%
Minimum
Sep 2020
-55.17%
Maximum
Dec 2019
-1.70K%
Average
-435.2%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| Biocure Technology Inc | -- |
| Core One Labs Inc | -897.6% |
| Nova Mentis Life Science Corp | -649.3% |
| Nanosphere Health Sciences Inc | -- |
| Lobe Sciences Ltd | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -42.38% |
| Return on Assets | -17.81% |
| Return on Invested Capital | -23.17% |
| Gross Profit Margin (Quarterly) | 3.01% |
| Operating Margin (Quarterly) | -269.3% |
| Return on Net Operating Assets | -30.55% |